ADALIMUMAB IS EFFECTIVE AND WELL-TOLERATED IN TREATING ANKYLOSING SPONDYLITIS (AS) IN REAL-LIFE CLINICAL PRACTICE: PRELIMINARY RESULTS OF THE RHAPSODY TRIAL

M. Rudwaleit , P. Claudepierre , P. Wordsworth , E. Loza , I. Olivieri , K. Boki , J. Vanhoof , I. Mantika , M. Kron , R. Carcereri , R. Wong , H. Kupper Rheumatology, Charité University Hospital, Berlin, Germany, CHU de Henri-Mondor, Créteil, France, Nuffield Orthopaedic Centre, Oxford, United Kingdom, Hospital de Navarra, Pamplona, Spain, San Carlo Hospital, Potenza, Italy, Sismanoglio Hospital, Athens, Greece, University Hasselt, Hasselt, Belgium, Abbott GmbH & Co KG, Ludwigshafen, GermanyCitation: Ann Rheum Dis, volume 66, supplement II, year 2007, page 619Session: Osteoarthritis – clinical aspects and treatment